Prometheus Biosciences Inc (RXDX) PT Lowered to $45 at RBC Capital

May 13, 2022 6:17 AM EDT Send to a Friend

RBC Capital analyst Gregory Renza ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Prometheus Biosciences Inc (RXDX) PT Lowered to $45 at RBC Capital

Member Login

Free News Feed